We read with interest the paper by Pavone and colleagues [1] describing the rapid reduction of fasting glucose (FG) levels in diabetic hepatitis C virus (HCV)-positive patients receiving directacting antiviral agents (DAAs). We aimed to assess if a similar decreasing trend of FG levels occurred in our study population and if it was maintained after the end of treatment (EOT). Therefore, we retrospectively evaluated 449 patients treated with DAAs at our centre (64 HIV/HCV coinfected),

HCV and diabetes: Towards a 'sustained' glycaemic improvement after treatment with DAAs?

SARACINO, ANNALISA;ANGARANO, Gioacchino
2017-01-01

Abstract

We read with interest the paper by Pavone and colleagues [1] describing the rapid reduction of fasting glucose (FG) levels in diabetic hepatitis C virus (HCV)-positive patients receiving directacting antiviral agents (DAAs). We aimed to assess if a similar decreasing trend of FG levels occurred in our study population and if it was maintained after the end of treatment (EOT). Therefore, we retrospectively evaluated 449 patients treated with DAAs at our centre (64 HIV/HCV coinfected),
File in questo prodotto:
File Dimensione Formato  
Fabrizio, CMI 2017.pdf

accesso aperto

Descrizione: articolo principale
Tipologia: Documento in Versione Editoriale
Licenza: Creative commons
Dimensione 370.22 kB
Formato Adobe PDF
370.22 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/180737
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 24
social impact